Skip to main content
Back to Wellington Management

Wellington Management's Pharmaceutical Portfolio

Browse 25 Pharmaceutical companies funded by Wellington Management. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
25
Total Funding in Pharmaceutical
$4.7B

Pharmaceutical Portfolio Companies (25)

Export
Health CareMedicalPharmaceutical

Judi Health is a healthtech platform that provides pharmacy benefit management solutions.

New York, United States
September 2025
$252.0M
Series F

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

San Diego, United States
September 2024
$27.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical DevicePharmaceutical

RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.

San Diego, United States
September 2022
$160.0M
Series D

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalNeurosciencePharmaceuticalTherapeutics

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

Waltham, United States
September 2025
$150.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics

Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.

San Diego, United States
September 2025
$690.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CarePharmaceutical

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

South San Francisco, United States
July 2024
$175.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.

Waltham, United States
June 2023
$200.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.

New York, United States
June 2026
$250.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Cambridge, United States
June 2026
$200.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics

Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.

Cambridge, United States
June 2026
$50.0M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.

Newton, United States
May 2022
$2.8M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

Cambridge, United States
April 2024
$160.5M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaHealth CarePharmaceutical

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Waltham, United States
March 2026
$100.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics

Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.

Munich, Germany
October 2025
$400.6M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

Seattle, United States
July 2025
$100.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

San Mateo, United States
May 2024
$182.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalMedical DevicePharmaceutical

Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.

Cambridge, United States
June 2023
$150.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaHealth CareMedicalPharmaceutical

Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.

New York, United States
November 2024
$215.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsLife SciencePharmaceutical

Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.

Cambridge, United States
November 2025
$250.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyClinical TrialsHealth CareMedicalPharmaceuticalTherapeutics

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Hayward, United States
October 2025
$250.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

Watertown, United States
October 2025
$225.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CareMedicalPharmaceutical

Tricida operates in the healthcare industry focusing on pharmaceutical business.

Menlo Park, United States
October 2022
$125.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product.

South San Francisco, United States
March 2021
$80.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

LianBio aims to develop and accelerate availability of paradigm-shifting medicines to patients in China.

Shanghai, China
October 2020
$310.0M
Series A

Founder Contacts

30,000+ verified contacts

Developer PlatformHealth CarePharmaceutical

Rhythm Metabolic develops a novel peptide MC4 agonist for the treatment of obesity caused by genetic deficiencies.

Boston, United States
August 2015
$40.0M
Series A

Founder Contacts

30,000+ verified contacts

Explore Wellington Management's Full Portfolio

View all companies funded by Wellington Management across every industry and funding stage.

View Full Wellington Management Portfolio